Table 1.
Study | Country | Study design | Vitamin D supplementation group | Non-vitamin D supplementation group | ||||
---|---|---|---|---|---|---|---|---|
|
|
|||||||
No. | Age | Sex, male | No. | Age | Sex, male | |||
Alcala-Diaz et al., 2021 | Spain | Retrospective, multicenter cohort study | 79 | 69 ± 15 | 42 (53.2%) | 458 | 67 ± 16 | 275 (60.0%) |
Annweiler et al., 2020 | France | Quasi-experimental study | 16 | 58.4 ± 7 | 11 (68.8%) | 32 | 64.1 ± 7.9 | 19 (59.4%) |
Castillo et al., 2020 | Spain | Parallel pilot randomized open label, double-masked clinical study | 50 | 56.8 ± 14.2 | 27 (54.0%) | 26 | 55.8 ± 15 | 18 (69.2%) |
Cereda et al., 2021 | Italy | Cohort observational study | 38 | 68.8 ± 10.6 | 16 (42.1%) | 286 | 70.5 ± 13.1 | 141 (49.3%) |
Hernández et al., 2020 | Spain | Retrospective case–control study | 19 | 63.5 ± 4.6 | 7 (36.8%) | 197 | 59.9 ± 3.8 | 123 (62.4%) |
Murai et al., 2021 | Brazil | Multicenter, double-blind, randomized, placebo-controlled study | 120 | 53.1 ± 10.8 | 70 (58.3%) | 120 | 52.8 ± 9.4 | 65 (54.2%) |
Nogues et al., 2021 | Spain | Observational cohort study | 447 | 61.8 ± 15.5 | 264 (59.1%) | 391 | 62.4 ± 17.2 | 231 (59.1%) |
Tan et al., 2020 | Singapore | Cohort observational study | 17 | 85.8 ± 1.5 | 11 (64.7%) | 26 | 88 ± 2.3 | 15 (57.7%) |